How can AEPi's leadership be connected with an organization that affiliates with individuals who want to see the demise of the Jewish people. [Read More]
People's lives—and the full reopening of the economy—depend on rolling out the Covid-19 vaccines as quickly as possible. 5 possible ideas. [Read More]
It has been just over a month since the U.S. began the most sweeping mass vaccination campaign in its history, and progress is already lagging... [Read More]
Calling the Covid-19 vaccine rollout a "dismal failure thus far," President-elect Joe Biden unveiled the outlines of a plan to bolster the vaccination effort. [Read More]
Text size ... [Read More]
Jefferies analyst David Windley has cast some doubt on investors' belief that the incoming Biden administration will greatly expand government healthcare... [Read More]
Anthem could benefit as the labor market recovers, says Jefferies. ... [Read More]
Results of a large Phase 3 trial are expected in the coming weeks. It is expected to show the single-dose vaccine is very effective, if... [Read More]
The company is behind schedule to meet commitments made to Operation Warp Speed, the newspaper said. [Read More]
Text size ... [Read More]
One analyst estimates that the deal could add $1.6 billion to the biotech's revenue. The deal gives the drug an effective price of $2,100 a... [Read More]
Chief Scientific Officer Mikael Dolsten says that Pfizer is working on a more stable formulation of its Covid-19 vaccine that will be easier to distribute. [Read More]
The comments highlight what is slowly becoming a consensus among experts: People may need to get regularly vaccinated against Covid-19 for years. [Read More]
Company CEO Alex Gorsky said at a conference that the company is in the "final stages" of analyzing the single-dose vaccine's efficacy. [Read More]
Half of the patients hospitalized with Covid-19 are receiving remdesivir, which is sold as Veklury, according to CEO Daniel O'Day. [Read More]
Text size ... [Read More]
The stock rose, as did shares of Biogen, which is developing a separate treatment. Lilly said its experimental drug slowed the cognitive decline of... [Read More]
Eli Lilly stock is up almost 20% over the past 12 months. ... [Read More]
The stock has dropped 46.4% over the past year even as the S&P 500 Health Care sector index has climbed 14.2%. [Read More]
test tubes Dreamstime ... [Read More]
Popular Tags
Hot Topics
- #1 Martin Luther King
- #2 President-Elect Joe Biden
- #3 Coronavirus
- #4 National Guard
- #5 Donald Trump
- #6 Electoral College
- #7 President Trump
- #8 Inauguration Day
- #9 Vice President Mike Pence
- #10 Capitol Police
- #11 House Speaker Nancy Pelosi
- #12 Black Lives Matter
- #13 Mega Millions
- #14 Capitol Building
- #15 Super Bowl
- #16 Disease Control
- #17 Ohio State
- #18 Public Health
- #19 MLK Day
- #20 New year's Eve
- #21 New year's Day
- #22 Kamala Harris
- #23 Washington AP
- #24 Human Services
- #25 United Kingdom
- #26 State Capitol
- #27 Urban Meyer
- #28 Paycheck Protection Program
- #29 First Amendment
- #30 Green Bay
- #31 Valentine's Day
- #32 James Harden
- #33 National Rifle Association
- #34 Cares Act
- #35 Dr Dre
- #36 House Democrats
- #37 George Floyd
- #38 Moderna Covid-19
- #39 Buffalo Bills
- #40 New York AP
- #41 Stop the Steal
- #42 Capitol Wednesday
- #43 Tampa Bay
- #44 Cleveland Browns
- #45 Big Tech
- #46 General Assembly
- #47 Robert Saleh
- #48 Jacksonville Jaguars
- #49 NFL Draft
- #50 HBO Max
